financetom
Business
financetom
/
Business
/
FedEx's Fiscal Q1 Miss Spurred by Slack Demand as Cost Savings Trail, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FedEx's Fiscal Q1 Miss Spurred by Slack Demand as Cost Savings Trail, Oppenheimer Says
Oct 3, 2024 12:25 AM

11:31 AM EDT, 09/20/2024 (MT Newswires) -- FedEx's ( FDX ) disappointing fiscal Q1 earnings reflected both slack demand and underperformance on cost savings, Oppenheimer said Friday in a report.

The $390 million from the company's DRIVE initiative to reduce expenses trailed the implied run-rate of the fiscal 2025 guidance of $2.2 billion, Oppenheimer said. Revenue eased in the quarter on "reduced demand for priority services, increased demand for deferred services and constrained yield growth," the company said Thursday.

The company affirmed its DRIVE cost-savings guidance and expects fiscal 2025 adjusted operating income of $7 billion, up from about $6.2 billion in fiscal 2024, Oppenheimer said.

Oppenheimer lowered its forecast for FedEx's ( FDX ) fiscal 2025 adjusted earnings $20.50 a share from $21, consistent with the midpoint of the company's tightened guidance.

Oppenheimer has a perform rating on the stock without any price target. At least a dozen other analysts reduced their price targets on FedEx ( FDX ).

Shares of FedEx ( FDX ) slumped 15% in recent trading Friday.

Price: 254.00, Change: -46.39, Percent Change: -15.44

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FTC sues drug 'gatekeepers' over high insulin prices
US FTC sues drug 'gatekeepers' over high insulin prices
Oct 3, 2024
(Reuters) -The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies. The case accuses UnitedHealth Group Inc's Optum unit, CVS Health Corp's CVS Caremark and Cigna Corp's Express Scripts of unfairly excluding lower...
FedEx's Fiscal Q1 Miss Spurred by Slack Demand as Cost Savings Trail, Oppenheimer Says
FedEx's Fiscal Q1 Miss Spurred by Slack Demand as Cost Savings Trail, Oppenheimer Says
Oct 3, 2024
11:31 AM EDT, 09/20/2024 (MT Newswires) -- FedEx's ( FDX ) disappointing fiscal Q1 earnings reflected both slack demand and underperformance on cost savings, Oppenheimer said Friday in a report. The $390 million from the company's DRIVE initiative to reduce expenses trailed the implied run-rate of the fiscal 2025 guidance of $2.2 billion, Oppenheimer said. Revenue eased in the quarter...
Market Chatter: JPMorgan Tests New Credit Card Internally as Part of UK Expansion Plans
Market Chatter: JPMorgan Tests New Credit Card Internally as Part of UK Expansion Plans
Oct 3, 2024
12:11 PM EDT, 09/20/2024 (MT Newswires) -- JPMorgan Chase ( JPM ) has started testing a new credit card internally as it looks to expand its products in the UK, Bloomberg News reported Friday, citing people familiar with the matter. This product has been under development for over a year and senior executives at JPMorgan ( JPM ) have been...
Onconetix to Implement 1-for-40 Reverse Stock Split to Regain Nasdaq Compliance; Shares Fall
Onconetix to Implement 1-for-40 Reverse Stock Split to Regain Nasdaq Compliance; Shares Fall
Oct 3, 2024
12:44 PM EDT, 09/20/2024 (MT Newswires) -- Onconetix ( ONCO ) said Friday that it will implement a 1-for-40 reverse stock split of its shares to help regain compliance with the minimum bid price requirement of $4.00 per share for initial listing on the Nasdaq Capital Market. The shares will begin trading on a reverse stock split-adjusted basis on Sept....
Copyright 2023-2026 - www.financetom.com All Rights Reserved